Nanomedicine News

RSS

Stable Nano-Carrier Releases Drugs Only in Diseased Cells

Medications often have unwanted side-effects. One reason is that they reach not only the unhealthy cells for which they are intended, but also reach and have an impact on healthy cells.

28 Sep 2020

New Nanodevice Acts Almost Like a Brain Cell

In the September issue of the journal Nature, scientists from Texas A&M University, Hewlett Packard Labs and Stanford University have described a new nanodevice that acts almost identically to a brain cell.

24 Sep 2020

Nanoparticle COVID-19 Model Could Potentially Speed the Search for Drugs

A team of scientists from the National Center for Advancing Translational Sciences and Naval Research Laboratory in Washington, D.C., has developed a new tool that mimics how SARS-CoV-2 -- the virus that causes COVID-19 -- infects a cell, information that could potentially speed the search for treatments against the disease.

22 Sep 2020

Researchers Develop Nanomedicine to Treat Prostate Cancer More Efficiently

Scientists have produced and patented a novel nanomedicine (theranostic system) for diagnosing and treating prostate cancer.

16 Sep 2020

Rubbery Properties of RNA Nanoparticles Provide High Tumor Targeting Efficiency

A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute shows that RNA nanoparticles have elastic and rubbery properties that help explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.

15 Sep 2020

New Nanoparticle Antitumor Vaccines Control Melanoma Growth in Preclinical Models

At the Wistar Institute, researchers merged synthetic DNA technology with their expertise in protein engineering to successfully create nanoparticle antitumor vaccines that stimulated strong CD8 T cell immunity and regulated melanoma growth in preclinical models.

11 Sep 2020

New Nano System Enhances the Effectiveness of Melanoma Treatment

Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU's Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system that significantly enhances the effectiveness of treatment for the aggressive skin cancer melanoma.

9 Sep 2020